CN102792166B - 子宫内膜接受性的诊断方法 - Google Patents

子宫内膜接受性的诊断方法 Download PDF

Info

Publication number
CN102792166B
CN102792166B CN201180010375.0A CN201180010375A CN102792166B CN 102792166 B CN102792166 B CN 102792166B CN 201180010375 A CN201180010375 A CN 201180010375A CN 102792166 B CN102792166 B CN 102792166B
Authority
CN
China
Prior art keywords
endometrial
pge2
pgf2α
sample
endometrium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180010375.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN102792166A (zh
Inventor
卡洛斯·西蒙瓦莱斯
安东尼奥·佩利塞尔马丁内斯
奥斯卡·贝兰加阿蒂恩萨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Equipo IVI Investigacion SL
Original Assignee
Equipo IVI Investigacion SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Equipo IVI Investigacion SL filed Critical Equipo IVI Investigacion SL
Publication of CN102792166A publication Critical patent/CN102792166A/zh
Application granted granted Critical
Publication of CN102792166B publication Critical patent/CN102792166B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CN201180010375.0A 2010-01-21 2011-01-21 子宫内膜接受性的诊断方法 Expired - Fee Related CN102792166B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382011.4 2010-01-21
EP10382011A EP2348318A1 (en) 2010-01-21 2010-01-21 Diagnostic method for endometrial receptivity
PCT/EP2011/050867 WO2011089240A1 (en) 2010-01-21 2011-01-21 Diagnostic method for endometrial receptivity

Publications (2)

Publication Number Publication Date
CN102792166A CN102792166A (zh) 2012-11-21
CN102792166B true CN102792166B (zh) 2015-10-21

Family

ID=42200845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180010375.0A Expired - Fee Related CN102792166B (zh) 2010-01-21 2011-01-21 子宫内膜接受性的诊断方法

Country Status (10)

Country Link
US (1) US20130144114A1 (enExample)
EP (2) EP2348318A1 (enExample)
JP (1) JP5732664B2 (enExample)
CN (1) CN102792166B (enExample)
BR (1) BR112012018289A2 (enExample)
CA (1) CA2787582A1 (enExample)
DK (1) DK2526425T3 (enExample)
ES (1) ES2485847T3 (enExample)
PL (1) PL2526425T3 (enExample)
WO (1) WO2011089240A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
US9107696B2 (en) * 2008-08-06 2015-08-18 Emory University Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus
ES2972747T3 (es) 2009-08-22 2024-06-14 Ares Trading Sa Obtención de imágenes y evaluación de embriones, ovocitos y células madre
WO2012047678A2 (en) 2010-09-27 2012-04-12 Auxogyn, Inc. Apparatus, method, and system for the automated imaging and evaluation of embryos, oocytes, and stem cells
CA2827945C (en) 2011-02-23 2021-10-12 The Board Of Trustees Of The Leland Stanford Junior University Methods of detecting aneuploidy in human embryos
WO2013135836A1 (en) * 2012-03-14 2013-09-19 Centre Hospitalier Universitaire Pontchaillou Itih5 as a diagnostic marker of uterine development and functional defects
EP2687851A1 (en) 2012-07-20 2014-01-22 Matricelab Innove Method for increasing implantation success in assisted fertilization
WO2014121200A1 (en) 2013-02-01 2014-08-07 Auxogyn, Inc. Abnormal syngamy phenotypes observed with time lapse imaging for early identification of embryos with lower developmental potential
RU2562559C1 (ru) * 2014-05-27 2015-09-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта" Северо-Западного отделения Российской академии медицинских наук Способ прогнозирования рецептивности эндометрия в циклах экстракорпорального оплодотворения
ES2736117T3 (es) 2014-06-17 2019-12-26 Igenomix S L Tratamiento de células madre en patologías endometriales
CN105486799B (zh) * 2016-01-25 2017-12-01 中国药科大学 用于诊断急性冠脉综合征的代谢标志物
CN105445408B (zh) * 2016-01-25 2018-06-12 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
EP3545107A2 (en) * 2016-11-22 2019-10-02 Quantbio Kft Determination of the receptive status of the endometrium
RU2651762C1 (ru) * 2017-06-14 2018-04-23 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ оценки рецептивности эндометрия в период "имплантационного окна"
EP3569718A1 (en) * 2018-05-16 2019-11-20 Integrated Genetic Lab Services SLU Kit and method for determining the receptivity status of an endometrium
AU2020212604A1 (en) * 2019-01-25 2021-07-22 Fertility Lab Sciences, Llc Uterine endometrial fluid for prediction of success in fertility treatment
WO2020160612A1 (en) * 2019-02-05 2020-08-13 The University Of Sydney Uterine receptivity
EP3779455A1 (en) * 2019-08-14 2021-02-17 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Lipid signatures for determining the outcome of embryo implantation during in vitro fertilization
CN111505311A (zh) * 2020-04-30 2020-08-07 深圳市锦欣医疗科技创新中心有限公司 一组胚胎反复种植失败的生物标志物、其筛选方法及应用
CN111505312A (zh) * 2020-04-30 2020-08-07 深圳市锦欣医疗科技创新中心有限公司 一组子宫内膜受容性的生物标志物、其筛选方法及应用
TWI791347B (zh) * 2020-12-11 2023-02-01 酷氏基因生物科技股份有限公司 一種用於評估胚胎植入成功率的預測方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501541A (ja) * 1989-05-05 1993-03-25 ノーザン　シドニー　エリア　ヘルス　サーヴィス 繁殖力増強
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US20040005612A1 (en) * 2002-05-14 2004-01-08 Giudice Linda C. Endometrial genes in endometrial disorders
DE10236405A1 (de) * 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
ES2273061T3 (es) * 2002-08-02 2007-05-01 Schering Aktiengesellschaft Agentes moduladores de receptores de progesterona con actividad antigonadotropa elevada para el control de fertilidad femenina y para la terapia por reemplazo hormonal.
CN1863905A (zh) * 2003-09-08 2006-11-15 得克萨斯系统大学董事会 通过用前列腺素或前列腺素类似物补充培养基加强体外胚发育的方法以及组合物
AU2005249504A1 (en) * 2004-05-28 2005-12-15 Laboratoires Serono Sa Use of IL-17 in the treatment of fertility-related disorders
JP2007278750A (ja) * 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CYCLIC CHANGES IN THE CONCENTRATION OF PROSTAGLANDIN F2α IN HUMAN UTERINE FLUSHINGS;J. B.MAATHU;《Briiish Journal of Obstetrics and Gymecology》;19781231;第85卷;第207-210页 *
Effect of dietary fat sources on systemic and intrauterine synthesis of prostaglandins during early pregnancy in gilts;R.Chartrand;《Journal of Animal Science》;20030331;第81卷(第3期);第726-734页 *
Effectoftheconceptusonuterineprostaglandin-F2α andprostaglandin-E2releaseandsynthesisduring theperiimplantationperiodinthepig;Marta Wasielak;《Reproduction,Fertility and Development》;20091231;第21卷;第709-717页 *
Hanna Achache.Endometrial receptivity markers,the journey to successful embryo implantation.《Human Reproduction Update》.2006,第12卷(第6期), *
Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology;Diederik Hoozemans;《Reproductive BioMedicine Online》;20041015;第9卷(第6期);第694页左栏第3段，右栏第2-4段，第698页右栏第1-2段，图6 *
Kristina Gemzell-Danielesson.The effect of antiproestin(RU486)and prostaglandin biosynthesis inhibitor(naproxen) on uterine fluid prostaglandin F2α concentrations.《Human Reproduction 》.1994,第9卷(第9期), *
前列腺素在胚胎着床和蜕膜化中的作用;邓文波;《细胞生物学杂志》;20081231;第30卷;第342-346页 *
米非司酮和抗雌激素对卵巢切除后怀孕大鼠子宫的PGF2α和PGE2浓度的影响;郑尧;《国外医学妇产科学分册》;19981231;第25卷(第1期);第43-第44页 *

Also Published As

Publication number Publication date
JP2013518244A (ja) 2013-05-20
US20130144114A1 (en) 2013-06-06
EP2348318A1 (en) 2011-07-27
BR112012018289A2 (pt) 2021-04-20
PL2526425T3 (pl) 2014-11-28
HK1177636A1 (zh) 2013-08-23
ES2485847T3 (es) 2014-08-14
DK2526425T3 (da) 2014-08-04
CA2787582A1 (en) 2011-07-28
WO2011089240A1 (en) 2011-07-28
EP2526425B1 (en) 2014-04-30
EP2526425A1 (en) 2012-11-28
CN102792166A (zh) 2012-11-21
JP5732664B2 (ja) 2015-06-10

Similar Documents

Publication Publication Date Title
CN102792166B (zh) 子宫内膜接受性的诊断方法
Edgell et al. Assessing receptivity in the endometrium: the need for a rapid, non-invasive test
Zachut et al. Proteomic analysis of preovulatory follicular fluid reveals differentially abundant proteins in less fertile dairy cows
JPH08507924A (ja) Ｉｖｆの結果の予測アッセイ
Lazzarin et al. Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle
Koh et al. Proteome profiling of exosomes derived from plasma of heifers with divergent genetic merit for fertility
Pier et al. Comprehensive profiling of prostaglandins in human ovarian follicular fluid using mass spectrometry
KR101467372B1 (ko) 타액을 이용한 생리활성 진단 방법
CN113748344A (zh) 肥胖孕妇先兆子痫风险的检测
Wang et al. Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay: correlation with pregnancy-associated hormone prolactin
US20220065866A1 (en) Uterine endometrial fluid for prediction of success in fertility treatment
KR20110068906A (ko) 타액을 이용한 생리활성 진단 방법
JP2002519640A (ja) 未受精卵の存在を示すためのアッセイ
WO2020225816A1 (en) Lipid profiling methods for predicting positive pregnancy outcome
HK1177636B (en) Diagnostic method for endometrial receptivity
Lee et al. Correlation of serum anti-Mullerian hormone to follicular follicle stimulating hormone and implantation potential of the ensuing embryos
Albayrak et al. A simple HPLC method for the determination of plasma progesterone levels in the third trimester of human pregnancy
EP2223106B1 (en) Embryo implantation
Pařízek et al. The Endocannabinoid System-The Prediction of Spontaneous Preterm Birth in High-Risk Women: Protocol of a Study
RU2797507C1 (ru) Способ прогнозирования эффективности вспомогательных репродуктивных технологий
EP4429543B1 (en) Method for determination of the window of implantation
US20070275431A1 (en) Detection of Preterm Labour
CN110785664A (zh) 流产中的特征性代谢物
TW202526323A (zh) 間質性膀胱炎之鑑別方法
JP2024545587A (ja) 着床の窓の決定方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1177636

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: IGENOMIX S. L.

Free format text: FORMER OWNER: IVI INVESTIGACION S. L.

Effective date: 20150529

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20150529

Address after: Valencia, Spain

Applicant after: Equipo IVI Investigacion S. L.

Address before: Valencia

Applicant before: Equipo IVI Investigacion S. L.

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1177636

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151021

Termination date: 20190121

CF01 Termination of patent right due to non-payment of annual fee